首页 | 本学科首页   官方微博 | 高级检索  
检索        

Molecular and immunohistochemical study of the inactivati on of the p16 gene in primary hepatocellular carcinoma
作者姓名:SHEN  Wenlü
作者单位:Department of General Surgery,The First ffiliated Hospital,Third Military Medical University!Chongqing400038,China,Department of General Surgey The First School of Medicine,West China University of Medical Sciences!Chengdu610041,China,Department of Genera
摘    要:Alterationsofp16geneareknowntooccurinmanyprimarytumors ,includingmelanoma ,pancreaticcancers ,esophagealsquamouscellcarcinoma ,braintumorsandthehematologicmalignancies 1 5 Inactivationofp16geneoccursviadifferentmechanisms ,includingthehomozygousdeletion,point…

关 键 词:hepatocellular  carcinoma  ·  p16  gene  mutation  ·  deletion  ·  methylation  ·  immunohistochemistry  

Molecular and immunohistochemical study of the inactivati on of the p16 gene in primary hepatocellular carcinoma
HUANG Jianzhao,SHEN Wenlü,LI Bo.Molecular and immunohistochemical study of the inactivati on of the p16 gene in primary hepatocellular carcinoma[J].Chinese Medical Journal,2000,113(10):889-893.
Authors:HUANG Jianzhao  SHEN Wenlü  LI Bo
Institution:Department of General Surgery, The First Affiliated Hospital, Third Military Medical University, Chongqing 400038, China;Department of General Surgey, The First School of Medicine, West China University of Medical Sciences, Chengdu 610041, China;Department of General Surgey, The First School of Medicine, West China University of Medical Sciences, Chengdu 610041, China;Department of General Surgey, The First School of Medicine, West China University of Medical Sciences, Chengdu 610041, China;Clinical Molecular Research Center, The First School of Medicine, West China University of Medical Sciences, Chengdu 610041, China;Clinical Molecular Research Center, The First School of Medicine, West China University of Medical Sciences, Chengdu 610041, China;Department of Pathology, The First School of Medicine, West China University of Medical Sciences, Chengdu 610041, China
Abstract:Objective To determine whether p16 gene is involved in the genesis of primary hepatocellular carcinoma (HCC). Methods Twenty-five HCC tumor samples with corresponding non-tumor liver tissue specimens were examined for p16 gene alterations. The identification of deletion of exon 1 and exon 2 in p16 gene was performed using comparative multiplex polymerase chain reaction (PCR) analysis. The point mutation of exon 2 in p16 gene was investigated by single strand conformational polymorphism (SSCP) analysis, and the status of p16 gene methylation was screened using a PCR based methylation analysis. 35 parafin-embedded specimens of HCC with corresponding non-tumor liver tissues, including the 25 cases described above for screening p16 gene alterations, were investigated for p16 protein expression using immunohistochemical analysis. Results Among 25 cases, 2 homozygous deletions and 1 hemizygous deletion were found in HCC samples. No point mutation was identified in the remaining 22 tumor samples without p16 gene deletions. Hypermethylation was detected in 24% (6/25) of tumor samples. However, the corresponding non-tumor liver tissue specimens were always unmethylated at the p16 locus. Loss of p16 protein expression occurred in 16 of 35 (45.7%) tumor samples, and all the non-tumor liver tissue specimens showed positive p16 staining. For the 25 cases examined for p16 gene alterations, the loss of p16 protein expression was observed in all tumors with p16 gene alterations and also in 3 tumors without p16 gene alterations. Conclusion Inactivation of the p16 gene may play an important role in the genesis of primary hepatocellular carcinoma.
Keywords:hepatocellular carcinoma  p16 gene mutation  deletion  methylation  immunohistochemistry
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中华医学杂志(英文版)》浏览原始摘要信息
点击此处可从《中华医学杂志(英文版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号